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Abstract Background: Contrast-enhanced ultrasound (CE-US), con-
trast CT scan and gadolinium dynamic MRI are recommended for the
characterization of liver nodules detected during surveillance of
patients with cirrhosis with US.
Aim: To assess the sensitivity, speciﬁcity, diagnostic accuracy and
economic impact of all possible sequential combinations of contrast
imaging techniques in patients with cirrhosis with 1–2 cm liver nod-
ules undergoing US surveillance.
Methods: Sixty four patients with 67 de novo liver nodules (55
with a size of 1–2 cm) were consecutively examined by CE-US,
CT, MRI, and a ﬁne-needle biopsy (FNB) as a diagnostic standard.
Undiagnosed nodules were re-biopsied; non-malignant nodules
underwent enhanced imaging follow-up. The typical radiological
feature of hepatocellular carcinoma (HCC) was arterial phase
hypervascularisation followed by portal/venous phase washout.
Results: HCC was diagnosed in 44 (66%) nodules (2, <1 cm; 34,
1–2 cm; 8, >2 cm). The sensitivity of CE-US, CT and MRI for
1–2 cm HCC was 26%, 44% and 44%, repectively, with 100% speciﬁc-
ity; the typical vascular pattern of HCC being identiﬁed in 22 (65%)
by a single technique versus 12 (35%) by at least two techniques car-
ried out at the same time point (p = 0.028). Compared with the
cheapest dual examination (CE-US + CT), the cheapest single tech-
nique of stepwise imaging diagnosis of HCC was equally expensive
(euro 26,440 versus euro 28,667) but led to a 23% reduction of
FNB procedures (p = 0.031).Journal of Hepatology 20
Keywords: Hepatocellular carcinoma; Liver biopsy; Ultrasound; Computed tom-
ography; Magnetic resonance imaging.
Received 12 July 2010; received in revised form 16 July 2010; accepted 16 July 2010
⇑ Address: Division of Diagnostic Imaging and Intervention, Department of Liver
Transplantation, Hepatology and Infectious Diseases, Pisa University School of
Medicine, Cisanello Hospital, Building No. 29, 2[nd] ﬂoor, IT-56124 Pisa, Italy.
Tel.: +39 050 996 560; fax +39 050 996 561.
E-mail address: lencioni@med.unipi.it.detected during surveillance, a single imaging technique showing a
typical contrast pattern conﬁdently permits the diagnosis of HCC,
thereby reducing the need for FNB examinations.
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by Elsevier B.V. All rights reserved.
Until 2000, the only accepted method to diagnose hepatocellular
carcinoma (HCC) was a positive biopsy ﬁnding. Unfortunately,
image-guided biopsy of nodular lesions in cirrhosis has limita-
tions. Obtaining an adequate sample may not be technically fea-
sible in lesions that are very small in size or in difﬁcult location
for percutaneous targeting. In addition, histologic differentiation
between HCC and non-malignant hepatocellular entities, espe-
cially high-grade dysplastic nodule, may be challenging on ﬁne-
needle biopsy specimens, since stromal invasion, one of the most
relevant criteria, is difﬁcult to recognize [1]. Last but not least,
biopsy involves the risk of serious complications, including bleed-
ing and tumor seeding along the needle track [2].
In 2000, a panel of experts on HCC convened in Barcelona on
behalf the European Association for the Study of the Liver (EASL)
and developed for the ﬁrst time non-invasive criteria for HCC based
on a combination of imaging and laboratory ﬁndings [3]. The non-
invasive criteria were restricted to cirrhotic patients undergoing
surveillance and included either (a) the detection of a focal lesion
larger than 2 cm showing evidence of arterial hypervascularization
in two coincident imaging techniques or (b) the detection of a focal
lesion larger than 2 cm showing evidence of arterial hypervascular-
ization in only one imaging technique but in association with an
alpha-fetoprotein (AFP) value exceeding 400 ng/ml. Biopsy, how-
ever, was still recommended for lesions smaller than 2 cm, particu-
larly those ranging 1–2 cm. For the tiny lesions below the 1 cm
threshold, the consensus was to schedule an enhanced follow-up,
given that most of such focal abnormalities detected by ultrasound
in a cirrhotic liver are not HCC, and that obtaining a deﬁnitive diag-
nosis of HCC was anyway considered unfeasible in the majority of
the cases.
In 2005, the guidelines for the clinical management of HCC
issued by the American Association for the Study of Liver
Diseases (AASLD) amended the EASL non-invasive criteria,
acknowledging that the newest imaging techniques – including
contrast-enhanced ultrasound, multidetector computed tomogra-
phy (CT), and thin-section dynamic magnetic resonance imaging
(MRI) – allowed for better exploration of the vascular pattern
of focal hepatic lesions. The AASLD guidelines recommended11 vol. 54 j 184–186
Table 1. Evolving criteria for imaging diagnosis of HCC in cirrhosis.
Diagnostic criteria
Author,
year   1 -2 cm  >2cm
Bruix et al., 
2001 [3]
Imaging pattern: arterial-phase hypervascularization
Biopsy
confirmation
required
Two coincident
imaging techniques 
One technique + AFP 
> 400 ng/ml
Bruix an
Sherman,
2005 [4]
d 
I
late phase washout
maging pattern: hypervascularization with venous /  
Sangiovanni
et al., 
2010 [6]
 (sequential 
application)
Two coincident
imaging techniques 
One imaging
 technique 
I
late phase washout
maging pattern: hypervascularization with venous /  
One imaging
 technique 
One imaging
 technique 
 (sequential 
application)
HCC, hepatocellular carcinoma. AFP, alpha-fetoprotein.
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dropping the use of AFP and to rely on a more comprehensive
enhancement pattern of HCC, including not only the detection
of hypervascularization in the arterial phase but also the evidence
of contrast washout in the venous or the late phase. While for
lesions above 2 cm a single imaging technique showing such
characteristic vascular proﬁle of HCC was considered adequate
to conﬁdently establish the diagnosis, in lesions ranging
1–2 cm, AASLD guidelines recommend that typical imaging
ﬁndings are conﬁrmed by two coincident dynamic imaging
modalities [4].
Prospective studies aimed at validating the AASLD guidelines
have conﬁrmed that these criteria are highly speciﬁc for the diag-
nosis of HCC. In a trial conducted in a series of consecutive
patients with a solitary focal lesion smaller than 2 cm detected
during ultrasound surveillance, the AASLD criteria achieved
100% speciﬁcity for the diagnosis of HCC [5]. Unfortunately, such
absolute speciﬁcity had the downside of very low sensitivity. As
a result, biopsy was still needed in about two thirds of the cases
[5].
In the article ‘‘The diagnostic and economic impact of contrast
imaging techniques in the diagnosis of small hepatocellular carci-
noma in cirrhosis”, Sangiovanni et al. suggest a different
approach to the diagnosis of HCC [6]. They propose a sequential
– rather than combined – application of imaging techniques.
They show that in the setting of surveillance, a single imaging
technique showing a typical contrast enhancement pattern
enables a conﬁdent diagnosis of HCC even in nodules ranging
1–2 cm. The use of a sequential algorithm maintains an absolute
speciﬁcity (100%) but increases the sensitivity from 35% (two
imaging techniques showing coincident typical vascular pattern
at the same time point, as per AASLD guidelines) to 65%, with sig-
niﬁcant savings in terms of liver biopsy procedures. In addition,
the stepwise imaging diagnosis was shown not to increase costs
with respect to the dual examination.
The paper by Sangiovanni et al. is a major contribution to the
diagnostic management of HCC. Correct characterization of nod-
ules ranging 1–2 cm in diameter is a key issue, since such small
lesions are the true target of surveillance programmes [2]. On
the other hand, the speciﬁcity of imaging diagnosis is crucial to
prevent therapeutic mistakes due to false positive diagnoses of
HCC. In this regard, an important caveat is the recent demonstra-
tion that intrahepatic colangiocellular carcinoma (ICC) in cirrho-
sis may show a similar enhancement pattern as HCC at contrast
ultrasound (arterial uptake followed by wash-out) [7]. Fortu-
nately, this overlap does not occur with MRI, since ICC, contrary
to HCC, does not show contrast washout in delayed phases [8].
Such a difference can be explained with the different pharmaco-
kinetic of ultrasound contrast agents with respect to iodinated
contrast agents for CT and gadolinium chelates for MRI. Ultra-
sound microbubbles are blood-pool agents, conﬁned to the intra-
vascular space, whereas the majority of currently approved
contrast agents for CT and MRI are rapidly cleared from the blood
into the extracellular space [9].
In conclusion, the ongoing progress in imaging techniques
requires continuous updates of diagnostic algorithms. In fact,
new approaches have been proposed at 5-year intervals during
the last decade (Table 1). At the same time, it is crucial that
every new approach is externally validated before its implemen-
tation on a large scale is recommended. In this regard, it is
important to point out that, despite the ability of state-of-the-
art imaging to assess tumor vascularity, neither the absence ofJournal of Hepatology 201arterial hypervascularization nor the absence of contrast wash-
out is the criterion for ruling out HCC. It is well established that
early stage HCC tumors may not exhibit the characteristic
vascular features of overt HCC. Delaying the diagnosis of HCC
until imaging detection of arterial hypervascularization or
wash-out could reduce the chances of a radical cure, since the
incidence of microscopic vascular invasion and satellite nodules
signiﬁcantly increases when a tumor develops imaging-detect-
able neoangiogenetic changes [10]. Alternate approaches – par-
ticularly the use of liver-speciﬁc MRI contrast agents – are
expected to improve the ability to characterize small lesions.
However, prospective investigation, with meticulous imaging-
pathology correlations on explanted livers, is warranted before
any alternate criterion is endorsed by scientiﬁc societies as
the standard diagnostic approach for HCC.Conﬂict of interest
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